Cite
APA Citation
Weinblatt, M., Mease, P., Mysler, E., Takeuchi, T., Drescher, E., Berman, A., Zilberstein, M., Xing, J., & Emery, P. (2014). sAT0244 A Phase Iib Study of the Efficacy and Safety of Subcutaneous Clazakizumab (ANTI-IL-6 Monoclonal Antibody) with or without Methotrexate in Adults with Moderate-To-Severe Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate. Annals of the rheumatic diseases, 73, 680–681. http://access.bl.uk/ark:/81055/vdc_100135155631.0x000056